NCT01110226 Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies Status TERMINATED Phase PHASE1
NCT01109524 Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01107639 Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE3
NCT01105390 AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma Status WITHDRAWN Phase PHASE2
NCT01104259 Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT01101451 Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Status COMPLETED Phase PHASE3
NCT01096368 Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Status COMPLETED Phase PHASE3
NCT01095302 Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01093092 Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE1
NCT01091454 Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01090466 Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium Status COMPLETED Phase PHASE1/PHASE2
NCT01089088 Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) Status COMPLETED Phase PHASE2
NCT01088802 Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx Status COMPLETED Phase PHASE2
NCT01088620 Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer Status SUSPENDED Phase PHASE2
NCT01088347 Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01087970 A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01086254 SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01084083 Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer Status COMPLETED Phase PHASE2
NCT01083537 Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction Status TERMINATED Phase PHASE1/PHASE2